Literature DB >> 26916773

Predicted burden of venous disease.

Sarah Onida1, Alun Huw Davies2.   

Abstract

Chronic venous disease is a common condition with clinical signs and symptoms ranging from spider veins, to varicose veins, to active venous ulceration. Both superficial and deep venous dysfunction may be implicated in the development of this disease. Socio-economic factors are shaping our population, with increasing age and body mass index resulting in significant pressure on healthcare systems worldwide. These risk factors also lead to an increased risk of developing superficial and/or deep venous insufficiency, increasing disease prevalence and morbidity. In this chapter, the authors review the current and future burden of chronic venous disease from an epidemiological, quality of life and economic perspective.
© The Author(s) 2016.

Entities:  

Keywords:  Deep vein thrombosis; cost effectiveness; epidemiology; quality of life assessment; varicose veins

Mesh:

Year:  2016        PMID: 26916773     DOI: 10.1177/0268355516628359

Source DB:  PubMed          Journal:  Phlebology        ISSN: 0268-3555            Impact factor:   1.740


  14 in total

Review 1.  Building a Successful Superficial Venous Program.

Authors:  Andrew Galmer; Jonathan Dunn; Maja Zaric; Joe F Lau; Mitchell Weinberg
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08

2.  Protocol for a systematic review and meta-analysis of interventions for pathologic perforator veins in chronic venous disease.

Authors:  Melissa Andreia de Moraes Silva; Ronald Luiz Gomes Flumignan; Fausto Miranda; Rodolfo Souza Cardoso; Seleno Glauber de Jesus Silva; Henrique Jorge Guedes; Luis Carlos Uta Nakano
Journal:  BMJ Open       Date:  2019-05-01       Impact factor: 2.692

3.  A variant of the castor zinc finger 1 (CASZ1) gene is differentially associated with the clinical classification of chronic venous disease.

Authors:  Gregory T Jones; Judith Marsman; Luba M Pardo; Tamar Nijsten; Marianne De Maeseneer; Vicky Phillips; Chi Lynch-Sutherland; Julia Horsfield; Jolanda Krysa; Andre M van Rij
Journal:  Sci Rep       Date:  2019-09-30       Impact factor: 4.379

4.  Burden and Suffering in Chronic Venous Disease.

Authors:  Andrew N Nicolaides; Nicos Labropoulos
Journal:  Adv Ther       Date:  2019-02-13       Impact factor: 3.845

Review 5.  The Seriousness of Chronic Venous Disease: A Review of Real-World Evidence.

Authors:  Alun H Davies
Journal:  Adv Ther       Date:  2019-02-13       Impact factor: 3.845

6.  Time trends and social security burden of temporary work disability due to chronic venous disease in Brazil.

Authors:  Raissa M da Coelho; Marco A P Nunes; Cristiane V C Gomes; Ilma S Dos Viana; Ângela M da Silva
Journal:  BMC Public Health       Date:  2020-04-10       Impact factor: 3.295

Review 7.  Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence.

Authors:  Jorge H Ulloa
Journal:  Adv Ther       Date:  2019-02-13       Impact factor: 3.845

8.  Study protocol for a multicentre, randomised controlled trial to compare the use of the decellularised dermis allograft in addition to standard care versus standard care alone for the treatment of venous leg ulceration: DAVE trial.

Authors:  Sarah Onida; Francine Heatley; Sarrah Peerbux; Layla Bolton; Tristan Lane; David Epstein; Manjit Gohel; Keith Poskitt; Nicky Cullum; John Norrie; Robert J Lee; Andrew Bradbury; Karen Dhillon; Akila Chandrasekar; Richard Lomas; A H Davies
Journal:  BMJ Open       Date:  2021-04-02       Impact factor: 2.692

9.  Anti-Inflammatory and Anti-Vascular Leakage Effects by Combination of Centella asiatica and Vitis vinifera L. Leaf Extracts.

Authors:  Myung-Gi Seo; Min-Jeong Jo; Nam In Hong; Min Jung Kim; Kyu Suk Shim; Eunju Shin; Jeong Jun Lee; Sang-Joon Park
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-14       Impact factor: 2.629

10.  Investigation of association between genetic polymorphisms of MMP2, MMP8, MMP9 and TIMP2 and development of varicose veins in the Slovak Population - pilot study.

Authors:  J Mazuchová; E Halašová; J Mazuch; M Šarlinová; V Valentová; M Franeková; Š Zelník; K Krkošková; K Javorka; M Péč; M Grendár
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.